002550.SZ
Changzhou Qianhong Biopharma Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 6.50
−3.42%Year over year
Reported trailing growth
- Revenue
- -2.5%
- EBITDA
- —
- EBIT
- -20.4%
- EPS
- -21.6%
- Free cash flow
- -16.0%
- Operating cash flow
- +3.1%
Forward estimates
Based on analyst estimates
- Revenue
- -44.4%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -12.0%
- EBITDA
- +7.0%
- EBIT
- +8.2%
- Net income
- +7.2%
- EPS
- +8.6%
- Free cash flow
- -28.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026